ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - ichthyol - משחה - ichthyol 10 %w/w - ichtasol - other antiseptics and disinfectants - for the disinfection of skin diseases.

ישראל - עברית - Ministry of Health

ben shimon floris ltd, israel - hydrogen peroxide - תמיסה - hydrogen peroxide 3 %w/w - other antiseptics and disinfectants - antiseptic.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - fusidic acid; hydrocortisone acetate - קרם - fusidic acid 2 %w/w; hydrocortisone acetate 1 %w/w - hydrocortisone and antiseptics - hydrocortisone and antiseptics - use in inflammatory dermatoses with secondary bacterial infection sensitive to fusidic acid. treatment of eczematous dermatoses.

ישראל - עברית - Ministry of Health

"ב.מדיקל לוגיסטיקס בע""מ " - רופא - "medical gels,medical device disinfectants&cleaning,hand antiseptic products,surface disinfectants,hemodialysis device cleaning solution,hygienic liquid soap,lead apron & accessories,hot & cold thermo gels,eeg paste,ecg spray&ecg cream,mouth care kit,stethoscope sterilization tape"

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 50 mg/ml; clavulanic acid as potassium salt 12.5 mg/ml - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to augmentin and are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - טבליות מצופות פילם - amoxicillin as trihydrate 250 mg; clavulanic acid as potassium salt 125 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused also by beta-lactamase producing organisms witch are susceptible to augmentin and are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - טבליות מצופות פילם - amoxicillin as trihydrate 500 mg; clavulanic acid as potassium salt 125 mg - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to augmentin and are resistant to other beta-lactam antibiotics.

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - bacitracin; neomycin as sulfate; polymyxin b sulfate - משחה לעין - bacitracin 400 u/g; polymyxin b sulfate 5000 u/g; neomycin as sulfate 5 mg/g - antibiotics in combination with other drugs - antibiotics in combination with other drugs - short term treatment of superficial external ocular infections caused by organisms susceptible to one or more of the antibiotics contained therein.

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - קרם - nystatin 100000 iu/g; gramicidin 0.25 mg/g; neomycin as sulfate 2.5 mg/g; triamcinolone acetonide 1 mg/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for local treatment of skin inflammations accompanied with mycotic and/or bacterial infection.

ישראל - עברית - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.